Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Revenues Up 2 Percent in Q4, Losses Narrow 18 Percent

NEW YORK, Feb. 19 (GenomeWeb News) - Gene Logic today reported a 2-percent increase in total revenues and a 6.5-percent decrease in net losses year over year.


Total revenue for the three month period ended Dec. 31, 2004, increased to $20 million $19.7 million for the year-ago period.


Gene Logic said it spent $967,000 on R&D in the quarter, up from $491,000 year over year.


Net loss for the quarter fell 18 percent to $4 million, or $.13 per share, from $4.9 million, or $.16 per share.


Cash and cash equivalents on hand as of Dec. 31 included $53 million and $50 million in marketable securities.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.